Same Indication

Pembrolizumab vs Trazodone

Pembrolizumab vs Trazodone: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Trazodone.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Trazodone — 5-9 hours.

Chemical Properties

Molecular Formula: Trazodone — C19H22ClN5O.

Molecular Weight: Trazodone — 371.8640 g/mol.

Type: Pembrolizumab — Antibody; Trazodone — Small molecule.